Indivior Pharmaceuticals (INDV) EBITDA (2024 - 2026)
Indivior Pharmaceuticals (INDV) recorded EBITDA of $162 million in Q2 2026, up 118.9% from $74 million a year earlier and up 16.5% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) EBITDA (2024 - 2026) Analysis & Trends
On a TTM basis, Indivior Pharmaceuticals' EBITDA came in at $430 million as of Jun 30, 2026, up 84.5% year-over-year; for FY2025, it was $272 million, up 403.7% from FY2024.
- Annual EBITDA has a four-year compound annual growth rate of 4.5% (FY2021 to FY2025).
- Across earlier years, EBITDA came in at $54 million in FY2024, -$137 million in FY2023, -$61 million in FY2022 and $228 million in FY2021.
- The Q2 2026 figure is the highest quarterly EBITDA in data going back to Q1 2024.
- On a year-over-year basis, EBITDA has increased for four consecutive quarters, with growth averaging 57.5% over the last five quarters.
- Per Business Quant, the preceding three quarters came in at $139 million (Q1 2026), $83 million (Q4 2025) and $46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Indivior Pharmaceuticals | 4.35 Bn | 3.32 Bn | 294.00 Mn | 162.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 162.00 Mn |
| Mar 31, 2026 | 139.00 Mn |
| Dec 31, 2025 | 83.00 Mn |
| Sep 30, 2025 | 46.00 Mn |
| Jun 30, 2025 | 74.00 Mn |
| Mar 31, 2025 | 69.00 Mn |
| Dec 31, 2024 | 51.00 Mn |
| Sep 30, 2024 | 39.00 Mn |
| Jun 30, 2024 | -116.00 Mn |
| Mar 31, 2024 | 80.00 Mn |
API Access
Indivior Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();